Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial

BACKGROUND: Studies from Asia indicate that normothermic intraperitoneal chemotherapy (NIPEC) may confer survival benefit in patients with gastric peritoneal carcinomatosis (PC). However, data regarding this approach is lacking in western population. The current STOPGAP trial is intended to assess 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Senthil, Maheswari, Dayyani, Farshid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985848/
https://www.ncbi.nlm.nih.gov/pubmed/36870941
http://dx.doi.org/10.1186/s12885-023-10680-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985848/
https://www.ncbi.nlm.nih.gov/pubmed/36870941
http://dx.doi.org/10.1186/s12885-023-10680-1

Ejemplares similares